Realtime | Geld | Brief | Zeit |
---|---|---|---|
63,88 | 64,10 | 01.10. | |
64,28 | 64,46 | 01.10. |
Stück | Geld | Kurs | Brief | Stück |
---|---|---|---|---|
64,88 | 1 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/2u3.htm [/URL] | ||||
20 | 47,000 | |||
Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
20 | 0,050 | 1 |
Uhrzeit | Aktienkurs | Stück |
---|---|---|
17:11:09 | 63,26 | 268 |
17:09:07 | 63,24 | 226 |
16:24:37 | 63,36 | 15 |
10:56:02 | 63,98 | 88 |
09:04:17 | 63,84 | 5 |
Tagesumsatz Xetra | -0,44 -0,69 % | 932 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Alcon, STAAR Surgical Announce Expiration Of HSR Waiting Period | 195 | AFX News | WASHINGTON (dpa-AFX) - Alcon (ALC) and STAAR Surgical Company (STAA) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection... ► Artikel lesen | |
Di | Alcon erreicht weiteren Schritt bei STAAR-Übernahme | 5 | cash | ||
Di | Alcon Inc. Investors and STAAR Surgical Company: Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon's Acquisition of STAAR | 192 | Business Wire | Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) ("STAAR"), the manufacturer of the Implantable Collamer®... ► Artikel lesen | |
Mo | Forecasting The Future: 10 Analyst Projections For Alcon | 3 | Benzinga.com | ||
ALCON Aktie jetzt für 0€ handeln | |||||
Mo | Broadwood files definitive proxy, STAAR reaffirms Alcon merger | 3 | Investing.com |
Zeit | Aktuelle Nachrichten | Medien | ||
---|---|---|---|---|
Mi | Gerresheimer erweitert Standort Wertheim für die Produktion von "ready-to-fill" Injektionsfläschchen | news aktuell-CH | Düsseldorf/Wertheim (ots) - Gerresheimer erweitert Standort Wertheim für die Produktion von "ready-to-fill" Injektionsfläschchen - Neue Produktionshalle für RTF-Fläschchen und innovative Verpackungsplattform... ► Artikel lesen | |
Mi | Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub | Business Wire | The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub... ► Artikel lesen | |
Mi | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
Mi | UnitedHealthcare Introduces 2026 Medicare Advantage Plans | AFX News | MINNETONKA (dpa-AFX) - Unitedhealth Group, Inc (UNH), Wednesday revealed its 2026 Medicare Advantage plans, which are intended to meet the changing needs of Medicare beneficiaries while providing... ► Artikel lesen | |
Mi | Sysmex, QIAGEN Announce Exclusive Distribution Partnership For Diagnostic Products In Japan | AFX News | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) and QIAGEN K.K., the Japanese subsidiary of QIAGEN N.V., announced on Wednesday that they have entered into a partnership for clinical diagnostic... ► Artikel lesen |